Phase I/II Trial of Autologous Tumor Cell Line–Derived Vaccines for Recurrent or Metastatic Sarcomas
- 1 October 2004
- journal article
- Published by Mary Ann Liebert Inc in Cancer Biotherapy & Radiopharmaceuticals
- Vol. 19 (5) , 581-588
- https://doi.org/10.1089/1084978042484812
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: